微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -41% | -241.67% | -85.69% | 66/68 | 4.88% | 沃华医药 | 9.22% | 行业排名> |
| 2025-06-30 | -22.08% | -278.73% | -154.38% | 66/68 | 3.21% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-03-31 | -8.68% | -364.17% | 84.15% | 66/68 | 2.25% | 羚锐制药 | 22.39% | 行业排名> |
| 2024-12-31 | -54.78% | -237.11% | -356.5% | 66/68 | 3.28% | 达仁堂 | 25.38% | 行业排名> |
| 2024-09-30 | -12% | -91.39% | -105.83% | 64/68 | 5.46% | 羚锐制药 | 13.67% | 行业排名> |
| 2024-06-30 | -5.83% | -118.35% | -211.76% | 64/68 | 2.54% | 天目药业 | 9.27% | 行业排名> |
| 2024-03-31 | -1.87% | -1084.21% | 88.49% | 63/68 | 1.97% | 天目药业 | 22.26% | 行业排名> |
| 2023-12-31 | -16.25% | 21.31% | -159.17% | 65/68 | 2.03% | 羚锐制药 | 20.44% | 行业排名> |
| 2023-09-30 | -6.27% | 41.29% | -134.83% | 65/68 | 7.62% | 羚锐制药 | 13.25% | 行业排名> |
| 2023-06-30 | -2.67% | 65.64% | -1505.26% | 64/68 | 5.2% | XD片仔癀 | 7.03% | 行业排名> |
| 2023-03-31 | 0.19% | 110.22% | 100.92% | 62/68 | 3.31% | XD片仔癀 | 23.1% | 行业排名> |
| 2022-12-31 | -20.65% | 7.36% | -93.35% | 65/68 | 6.79% | 太极集团 | 22.08% | 行业排名> |
| 2022-09-30 | -10.68% | -2372.34% | -37.45% | 65/68 | 5.19% | 太极集团 | 17.13% | 行业排名> |
| 2022-06-30 | -7.77% | -1353.23% | -317.74% | 65/68 | 3.33% | 以岭药业 | 10.43% | 行业排名> |
| 2022-03-31 | -1.86% | -373.53% | 91.66% | 63/68 | 2.18% | *ST吉药 | 72.63% | 行业排名> |
| 2021-12-31 | -22.29% | -641.02% | -4842.55% | 63/68 | 4.51% | XD片仔癀 | 23.54% | 行业排名> |
| 2021-09-30 | 0.47% | -88.67% | -24.19% | 61/68 | 7.47% | XD片仔癀 | 19.69% | 行业排名> |
| 2021-06-30 | 0.62% | -83.98% | -8.82% | 61/68 | 4.6% | XD片仔癀 | 12.75% | 行业排名> |
| 2021-03-31 | 0.68% | -70.18% | -83.5% | 58/68 | 2.63% | XD片仔癀 | 6.88% | 行业排名> |
| 2020-12-31 | 4.12% | 635.06% | -0.72% | 45/68 | 0.07% | XD片仔癀 | 27.39% | 行业排名> |
| 2020-09-30 | 4.15% | 56.6% | 7.24% | 47/68 | 6.89% | XD片仔癀 | 23.14% | 行业排名> |
| 2020-06-30 | 3.87% | 1582.61% | 69.74% | 34/68 | 3.83% | XD片仔癀 | 13.23% | 行业排名> |
| 2020-03-31 | 2.28% | 153.33% | 396.1% | 27/68 | 2.18% | 长药退 | 7.37% | 行业排名> |
| 2019-12-31 | -0.77% | 42.54% | -129.06% | 59/68 | 6.88% | 以岭药业 | 7.15% | 行业排名> |
| 2019-09-30 | 2.65% | 0% | 1052.17% | 52/68 | 7.39% | 沃华医药 | 22.84% | 行业排名> |
| 2019-06-30 | 0.23% | 0% | -74.44% | 61/68 | 4.75% | 沃华医药 | 19.47% | 行业排名> |
| 2019-03-31 | 0.9% | 20% | 167.16% | 57/68 | 2.94% | 沃华医药 | 12.7% | 行业排名> |
| 2018-12-31 | -1.34% | 69.75% | -150.57% | 59/68 | 7.89% | 济川药业 | 7.33% | 行业排名> |
| 2018-09-30 | 2.65% | 29.27% | 1052.17% | 54/68 | 8.02% | 济川药业 | 27.43% | 行业排名> |
| 2018-06-30 | 0.23% | -69.74% | -69.33% | 59/68 | 5.05% | 济川药业 | 23.05% | 行业排名> |
| 2018-03-31 | 0.75% | 13.64% | 116.93% | 56/68 | 2.78% | 济川药业 | 15.79% | 行业排名> |
| 2017-12-31 | -4.43% | -1063.04% | -316.1% | 63/68 | 9.95% | 华润三九 | 10.23% | 行业排名> |
| 2017-09-30 | 2.05% | -8.89% | 169.74% | 57/68 | 8.4% | 济川药业 | 32.79% | 行业排名> |
| 2017-06-30 | 0.76% | -46.1% | 15.15% | 60/68 | 5.23% | 济川药业 | 27.55% | 行业排名> |
| 2017-03-31 | 0.66% | -28.26% | 43.48% | 53/68 | 2.66% | 济川药业 | 17.62% | 行业排名> |
| 2016-12-31 | 0.46% | -91.97% | -79.56% | 59/68 | 10.19% | 济川药业 | 10.07% | 行业排名> |
| 2016-09-30 | 2.25% | -60.53% | 59.57% | 52/68 | 9.47% | ST葫芦娃 | 46.01% | 行业排名> |
| 2016-06-30 | 1.41% | -70.87% | 53.26% | 55/68 | 5.15% | 济川药业 | 24.2% | 行业排名> |
| 2016-03-31 | 0.92% | -54% | -83.94% | 47/68 | 4.17% | *ST大药 | 15.31% | 行业排名> |